These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 36922901
1. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain. Wang PY, Kuo TY, Wang LH, Liang WH, Wang GS. Acta Neuropathol Commun; 2023 Mar 15; 11(1):44. PubMed ID: 36922901 [Abstract] [Full Text] [Related]
2. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy. Wang PY, Lin YM, Wang LH, Kuo TY, Cheng SJ, Wang GS. Hum Mol Genet; 2017 Jun 15; 26(12):2247-2257. PubMed ID: 28369378 [Abstract] [Full Text] [Related]
3. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. de Haro M, Al-Ramahi I, De Gouyon B, Ukani L, Rosa A, Faustino NA, Ashizawa T, Cooper TA, Botas J. Hum Mol Genet; 2006 Jul 01; 15(13):2138-45. PubMed ID: 16723374 [Abstract] [Full Text] [Related]
4. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I. Zhang F, Bodycombe NE, Haskell KM, Sun YL, Wang ET, Morris CA, Jones LH, Wood LD, Pletcher MT. Hum Mol Genet; 2017 Aug 15; 26(16):3056-3068. PubMed ID: 28535287 [Abstract] [Full Text] [Related]
5. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. Suenaga K, Lee KY, Nakamori M, Tatsumi Y, Takahashi MP, Fujimura H, Jinnai K, Yoshikawa H, Du H, Ares M, Swanson MS, Kimura T. PLoS One; 2012 Aug 15; 7(3):e33218. PubMed ID: 22427994 [Abstract] [Full Text] [Related]
6. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. Dansithong W, Wolf CM, Sarkar P, Paul S, Chiang A, Holt I, Morris GE, Branco D, Sherwood MC, Comai L, Berul CI, Reddy S. PLoS One; 2008 Aug 15; 3(12):e3968. PubMed ID: 19092997 [Abstract] [Full Text] [Related]
12. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. J Cell Sci; 2005 Jul 01; 118(Pt 13):2923-33. PubMed ID: 15961406 [Abstract] [Full Text] [Related]
13. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development. Michel L, Huguet-Lachon A, Gourdon G. PLoS One; 2015 Jul 01; 10(9):e0137620. PubMed ID: 26339785 [Abstract] [Full Text] [Related]
15. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy. Christou M, Wengel J, Sokratous K, Kyriacou K, Nikolaou G, Phylactou LA, Mastroyiannopoulos NP. Nucleic Acid Ther; 2020 Apr 01; 30(2):80-93. PubMed ID: 31873063 [Abstract] [Full Text] [Related]
16. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. Dansithong W, Paul S, Comai L, Reddy S. J Biol Chem; 2005 Feb 18; 280(7):5773-80. PubMed ID: 15546872 [Abstract] [Full Text] [Related]
18. FISH Protocol for Myotonic Dystrophy Type 1 Cells. Klein AF, Arandel L, Marie J, Furling D. Methods Mol Biol; 2020 Feb 18; 2056():203-215. PubMed ID: 31586350 [Abstract] [Full Text] [Related]